Sepsis & infection

NEWS2 versus shock status to stratify antibiotic urgency in patients with suspected sepsis: a retrospective, multicentre cohort study

Lancet Respir MedPublished Retrospective cohort study

Authors' conclusion

The NICE-defined high-risk NEWS2 category (scores ≥7) identified patients in whom each additional hour to antibiotic administration was associated with increased mortality, including many without shock, whereas no association was observed for lower NEWS2 scores.

Study context

Population
Adults admitted via the EDs of nine Mass General Brigham hospitals (MA, US) treated for suspected infection (blood culture and IV antibiotics within 6 h of ED arrival), 2015–2024
Exposure
Shock status vs laboratory-upgraded NEWS2 (NEWS2+) categories to stratify association of antibiotic delay with mortality
  • Shockn = 4,867
  • NEWS2+ 0n = 9,672
  • NEWS2+ 1-4n = 37,310
  • NEWS2+ 5-6n = 26,134
  • NEWS2+ ≥7n = 26,551
Outcome
Hospital mortality per additional hour to antibiotic administration
Methodological detailsmulticentre
  • Multicentre

Main finding

As reported in the abstract

Hospital mortality per additional hour to antibiotics
Adjusted odds ratio per hour (95% CI)
Shock1.5% absolute increase per hour, 95% CI 0.5-2.4
1.15(1.07–1.25)
No shocknot associated
1.03(1.00–1.05)
NEWS2+ ≥70.5% absolute increase per hour, 95% CI 0.3-0.8
1.07(1.04–1.11)

Each row per its own increment, as printed

Observational data: associations, not effects.

Further findings

OutcomeValuesaOR per hour (CI)
Hospital mortality per hour, NEWS2+ ≥7 without shock (subgroup)0.4% absolute increase per hour, 95% CI 0.1-0.6%NEWS2+ ≥7 without shock 86.3%1.05 (1.01–1.09)

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

NEWS2 versus shock status to stratify antibiotic urgency in patients with suspected sepsis: a retrospective, multicentre cohort study. Lancet Respir Med. Published 5 August 2026. doi:10.1016/s2213-2600(26)00187-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.